| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 52.81M | 42.78M | 37.84M | 34.80M | 32.96M | 18.74M |
| Gross Profit | 27.09M | 22.46M | 19.61M | 16.04M | 14.85M | 8.27M |
| EBITDA | 8.99M | 7.76M | 7.72M | 6.66M | 8.80M | 4.31M |
| Net Income | 4.24M | 4.37M | 4.66M | 4.24M | 6.31M | 3.13M |
Balance Sheet | ||||||
| Total Assets | 60.23M | 61.24M | 30.74M | 27.82M | 25.90M | 13.77M |
| Cash, Cash Equivalents and Short-Term Investments | 4.04M | 6.33M | 8.45M | 7.35M | 6.57M | 3.68M |
| Total Debt | 20.68M | 21.50M | 3.57M | 3.94M | 4.31M | 1.61M |
| Total Liabilities | 34.37M | 34.25M | 11.44M | 10.08M | 9.12M | 4.29M |
| Stockholders Equity | 25.87M | 26.99M | 19.30M | 17.74M | 16.78M | 9.48M |
Cash Flow | ||||||
| Free Cash Flow | 4.34M | 3.53M | 4.93M | 4.19M | 4.08M | 2.05M |
| Operating Cash Flow | 6.34M | 6.60M | 6.28M | 6.15M | 5.21M | 3.32M |
| Investing Cash Flow | -25.41M | -25.15M | -1.14M | -1.90M | -1.12M | -587.78K |
| Financing Cash Flow | 14.83M | 16.42M | -4.03M | -3.47M | -2.65M | -2.14M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | £1.69B | 8.95 | 9.27% | 1.62% | 0.50% | 20.52% | |
74 Outperform | £30.89B | 7.58 | 13.57% | 3.25% | 1.05% | -20.25% | |
70 Outperform | £84.70M | 11.22 | 16.03% | 5.12% | 36.73% | -18.26% | |
70 Outperform | £7.85B | 11.60 | 5.08% | 4.02% | 0.82% | 160.81% | |
68 Neutral | £1.64B | 14.01 | 20.47% | 3.34% | 8.06% | 5.15% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
52 Neutral | £1.56B | 3.62 | 24.47% | ― | ― | ― |